Published in Neurology on June 01, 1995
Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome. Neurology (2005) 1.59
Thinning of sensorimotor cortices in children with Tourette syndrome. Nat Neurosci (2008) 1.38
Prefrontal and anterior cingulate cortex abnormalities in Tourette Syndrome: evidence from voxel-based morphometry and magnetization transfer imaging. BMC Neurosci (2009) 1.26
Imaging evidence for anatomical disturbances and neuroplastic compensation in persons with Tourette syndrome. J Psychosom Res (2009) 1.16
Advances in understanding and treatment of Tourette syndrome. Nat Rev Neurol (2011) 1.07
Altered intrahemispheric structural connectivity in Gilles de la Tourette syndrome. Neuroimage Clin (2013) 0.92
Gilles de la Tourette's syndrome and its impact in the UK. Postgrad Med J (2005) 0.90
Animal models of tic disorders: a translational perspective. J Neurosci Methods (2014) 0.87
Interhemispheric connectivity and executive functioning in adults with Tourette syndrome. Neuropsychology (2006) 0.86
Three cases of symptom change in Tourette's syndrome and obsessive-compulsive disorder associated with paediatric cerebral malignancies. J Neurol Neurosurg Psychiatry (1996) 0.86
Handedness, heritability, neurocognition and brain asymmetry in schizophrenia. Brain (2010) 0.85
Memory and executive functions in adults with Gilles de la Tourette syndrome and chronic tic disorder. Cogn Neuropsychiatry (2007) 0.84
Abnormal baseline brain activity in drug-naïve patients with Tourette syndrome: a resting-state fMRI study. Front Hum Neurosci (2014) 0.84
Neuroimaging of tic disorders with co-existing attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry (2007) 0.84
Electrophysiological manifestations of stimulus evaluation, response inhibition and motor processing in Tourette syndrome patients. Psychiatry Res (2009) 0.82
Pediatric Tourette syndrome: insights from recent neuroimaging studies. J Obsessive Compuls Relat Disord (2014) 0.82
Postural control anomalies in children with Tourette syndrome. Exp Brain Res (2007) 0.82
The role of abnormal neural oscillations in the pathophysiology of co-occurring Tourette syndrome and attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry (2007) 0.81
Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits. Curr Top Dev Biol (2014) 0.81
Psychopharmacology of tic disorders. J Can Acad Child Adolesc Psychiatry (2008) 0.80
The Normal Inhibition of Associations is Impaired by Clonidine in Tourette Syndrome. J Can Acad Child Adolesc Psychiatry (2011) 0.78
Functional asymmetries in the movement kinematics of patients with Tourette's syndrome. J Neurol Neurosurg Psychiatry (1997) 0.78
Multivariate pattern classification of pediatric Tourette syndrome using functional connectivity MRI. Dev Sci (2016) 0.77
Neuroimaging in Tourette Syndrome: Research Highlights From 2014-2015. Curr Dev Disord Rep (2015) 0.76
Neurosurgical strategies for Gilles de la Tourette's syndrome. Neuropsychiatr Dis Treat (2008) 0.75
Putting the Pieces Together in Gilles de la Tourette Syndrome: Exploring the Link Between Clinical Observations and the Biological Basis of Dysfunction. Brain Topogr (2016) 0.75
Repetitive Behavior in Neurodevelopmental Disorders: Clinical and Translational Findings. Behav Anal (2015) 0.75
Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A (2001) 9.42
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry (2005) 9.23
Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry (1987) 8.81
Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry (1986) 4.34
Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex (2000) 3.37
Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex (1999) 3.31
Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med (1990) 3.10
Neuropsychological assessment of monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry (1990) 3.07
Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A (1997) 3.00
Episodic multiregional cortical coherence at multiple frequencies during visual task performance. Nature (1993) 2.85
Evidence for abnormal cortical functional connectivity during working memory in schizophrenia. Am J Psychiatry (2001) 2.80
Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry (2000) 2.62
Noise reduction in 3D perfusion imaging by attenuating the static signal in arterial spin tagging (ASSIST). Magn Reson Med (2000) 2.58
Guidelines for the recording and quantitative analysis of electroencephalographic activity in research contexts. Psychophysiology (1993) 2.57
Neurophysiological correlates of age-related changes in human motor function. Neurology (2002) 2.52
Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch Gen Psychiatry (1997) 2.48
A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry (2000) 2.32
Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology (2000) 2.28
Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. Arch Gen Psychiatry (1987) 2.24
Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry (2006) 2.22
H(2)(15)O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans. Magn Reson Med (2000) 2.20
Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women. Proc Natl Acad Sci U S A (1997) 2.19
Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol Psychiatry (2003) 2.18
Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry (2007) 2.12
Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biol Psychiatry (2001) 2.08
Schizophrenia and temporal lobe epilepsy. A neuropsychological analysis. Arch Gen Psychiatry (1994) 2.07
Relative risk of attention deficits in siblings of patients with schizophrenia. Am J Psychiatry (2000) 2.07
Genetic contributions to regional variability in human brain structure: methods and preliminary results. Neuroimage (2002) 2.01
Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology (1993) 1.99
Lateral cerebral ventricular enlargement in chronic schizophrenia. Arch Gen Psychiatry (1979) 1.94
Genetic variability of human brain size and cortical gyral patterns. Brain (1997) 1.92
Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. Arch Neurol (1992) 1.91
Cognitive substrates of thought disorder, I: the semantic system. Am J Psychiatry (1998) 1.90
To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology (2000) 1.89
Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients. Blood (1996) 1.88
Serotonergic dysfunction, negative mood states, and response to alcohol. Alcohol Clin Exp Res (2001) 1.85
Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery. Am J Psychiatry (1993) 1.78
The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia. Br J Psychiatry (1993) 1.75
Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience (2003) 1.74
Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans. Mol Psychiatry (2008) 1.70
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life. Dig Liver Dis (2005) 1.69
Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Mol Psychiatry (2008) 1.66
Physiological activation of a cortical network during performance of the Wisconsin Card Sorting Test: a positron emission tomography study. Neuropsychologia (1995) 1.65
COMT genotype predicts cortical-limbic D1 receptor availability measured with [11C]NNC112 and PET. Mol Psychiatry (2008) 1.63
Effects of dextroamphetamine on cognitive performance and cortical activation. Neuroimage (2000) 1.63
Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry (2004) 1.62
Correction for vascular artifacts in cerebral blood flow values measured by using arterial spin tagging techniques. Magn Reson Med (1997) 1.61
The relationship between dorsolateral prefrontal N-acetylaspartate measures and striatal dopamine activity in schizophrenia. Biol Psychiatry (1999) 1.60
Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. IV. Further evidence for regional and behavioral specificity. Arch Gen Psychiatry (1988) 1.58
GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol Psychiatry (2005) 1.56
Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol (2000) 1.56
Functional magnetic resonance imaging brain mapping in psychiatry: methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology (1998) 1.54
The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev Psychopathol (2000) 1.54
Genetic variation in MAOA modulates ventromedial prefrontal circuitry mediating individual differences in human personality. Mol Psychiatry (2007) 1.54
Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. Arch Gen Psychiatry (1993) 1.52
Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk. Mol Psychiatry (2008) 1.51
Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology (Berl) (1995) 1.48
Is the mechanism of prefrontal hypofunction in depression the same as in schizophrenia? Regional cerebral blood flow during cognitive activation. Br J Psychiatry (1993) 1.47
Catechol-o-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan. Cereb Cortex (2006) 1.46
Temporary stoma after elective anterior resection of the rectum: an unsolved debate. Colorectal Dis (2005) 1.46
A comparison of rCBF patterns during letter and semantic fluency. Neuropsychology (2000) 1.45
Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia. Schizophr Res (2012) 1.44
The distribution of cerebral muscarinic acetylcholine receptors in vivo in patients with dementia. A controlled study with 123IQNB and single photon emission computed tomography. Arch Neurol (1991) 1.44
Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort. Arch Gen Psychiatry (1986) 1.42
MRI asymmetries of Broca's area: the pars triangularis and pars opercularis. Brain Lang (1998) 1.41
Increase of bradykinin in plasma of patients undergoing cardiopulmonary bypass: the importance of lung exclusion. Chest (2001) 1.41
A quantitative analysis of smooth pursuit eye tracking in monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry (1997) 1.41
Localization of epidermal growth factor receptors and putative neuroblasts in human subependymal zone. J Comp Neurol (2000) 1.40
Hemispheric control of motor function: a whole brain echo planar fMRI study. Psychiatry Res (1998) 1.38
Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia. Mol Psychiatry (2007) 1.38
Surgical treatment of hydatid disease of the liver. A 20-year experience. Arch Surg (1991) 1.37
Specific versus nonspecific brain activity in a parametric N-back task. Neuroimage (2000) 1.32
Evidence that many of the DISC1 isoforms in C57BL/6J mice are also expressed in 129S6/SvEv mice. Mol Psychiatry (2007) 1.32
Relationship of birth weight to the phenotypic expression of Gilles de la Tourette's syndrome in monozygotic twins. Neurology (1992) 1.31
Reduced central serotonin transporters in alcoholism. Am J Psychiatry (1998) 1.31
Relationship of obstetric complications and differences in size of brain structures in monozygotic twin pairs discordant for schizophrenia. Am J Psychiatry (2000) 1.31
Intermediate phenotypes in schizophrenia genetics redux: is it a no brainer? Mol Psychiatry (2008) 1.30
Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood. Psychopharmacology (Berl) (1997) 1.30
Dopamine, the prefrontal cortex and schizophrenia. J Psychopharmacol (1997) 1.30
Operant conditioning and the orbitofrontal cortex in schizophrenic patients: unexpected evidence for intact functioning. Schizophr Res (1998) 1.28
Workshop on schizophrenia. Proc Natl Acad Sci U S A (1997) 1.28
Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. Am J Psychiatry (2000) 1.28
Correlation between computed tomography and intracranial pressure monitoring in acute head trauma patients. Radiology (1979) 1.27
Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia. Mol Psychiatry (2005) 1.27
Prognostic factors after surgical resection for pancreatic carcinoma. J Surg Oncol (2000) 1.26
Schizophrenia: reduced signal-to-noise ratio and impaired phase-locking during information processing. Clin Neurophysiol (2000) 1.25
Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls. Mol Psychiatry (2006) 1.25
Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry (1996) 1.23
Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development. Mol Psychiatry (2003) 1.23
The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biol Psychiatry (2001) 1.22
No difference in basal ganglia mineralization between schizophrenic and nonschizophrenic patients: a quantitative computerized tomographic study. Biol Psychiatry (1990) 1.21
Forms of memory failure in schizophrenia. J Abnorm Psychol (1992) 1.20
Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways. Mol Psychiatry (2010) 1.20